Company performance
Current Price
as of Jan 17, 2025$3.20
P/E Ratio
N/A
Market Cap
$606.37M
- ONT
Description
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.
Metrics
Overview
- HQWarminster, PA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerABUS
- Price$3.2-0.62%
Trading Information
- Market cap$606.37M
- Float77.78%
- Average Daily Volume (1m)802,366
- Average Daily Volume (3m)850,804
- EPS-$0.43
Company
- Revenue$6.74M
- Rev growth (1yr)-71.25%
- Net income-$19.72M
- Gross margin74.91%
- EBITDA margin-1,279.69%
- EBITDA-$17.13M
- EV$606.61M
- EV/Revenue89.97
- P/EN/A
- P/S89.71
- P/B5.67
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset